Stada-led €4bn loan spree could push lev pricing wider

The European leveraged finance market is set to contend with loan deals approaching €4bn for the start of September. Over half of that is for the German pharmaceutical firm Stada — a deal that could help make funding more expensive for everyone else, writes Victor Jimenez.

  • By Victor Jimenez
  • 31 Aug 2017

“Every investor is waiting for the Stada loans,” said a leveraged finance banker in London.

Some of the bankers working on Stada, the flashiest and most anticipated deal in the European leveraged loan market for the second ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 30,388.71 99 8.63%
2 BNP Paribas 22,463.54 135 6.38%
3 Deutsche Bank 17,970.47 100 5.10%
4 Goldman Sachs 17,954.81 74 5.10%
5 HSBC 16,143.35 101 4.58%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 472.73 3 8.70%
2 Goldman Sachs 460.40 3 8.48%
3 Credit Suisse 417.53 4 7.69%
4 Barclays 413.98 4 7.62%
5 Credit Agricole CIB 353.26 2 6.50%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 1,942.03 15 9.59%
2 Bank of America Merrill Lynch 1,559.21 15 7.70%
3 Wells Fargo Securities 1,535.51 14 7.58%
4 JPMorgan 1,388.05 13 6.85%
5 Morgan Stanley 1,381.20 11 6.82%